Multicenter prospective study of stereotactic body radiotherapy for untreated solitary primary hepatocellular carcinoma

Phase 2

• Conditions: ntreated solitary primary hepatocellular carcinoma

• Registration Number: JPRN-UMIN000013011
• Lead Sponsor: STRSPH study group

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-01-30
• Study Completion: 2020-02-28
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

Not provided

Exclusion Criteria

1)Ascites uncontrollable with medication 2)History of radiation therapy to the lesion of interest 3)Having esophageal varices which are at great risk of bleeding 4)Having active infectious diseases 5)Associated with other malignancies (simultaneous double cancer and heterochronic double cancer with disease-free time within 5 years), excluding carcinoma-in-situ or submucosal carcinoma treated with curative local therapies, glottis cancer staged as T1N0M0, low-risk prostate cancer (T1-2a, Gleason score 2-6 and PSA < 10 ng/ml), Stage I breast cancer, and other malignancies with comparatively favorable prognosis 6)Having interstitial pneumonitis, pulmonary fibrosis or severe respiratory disease such as pulmonary emphysema 7)Associated with mental illness or manifestation complicating study participation 8)Being pregnant or possible conception 9) Miscellaneous inappropriate conditions judged by physicians

Study & Design

• Study Type: Interventional
• Study Design: Not specified